Papp, Eva – Trademark Portfolio

Entity Type: 01

Papp, Eva holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DAE NOVA. The owner is based in Seattle, WA.

2434 S. Irving St.

Seattle, WA 98144

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DAE NOVA
DAE NOVA
Registered 2021
MEDSEZ
MEDSEZ
Abandoned 2008

Trademark Classifications

Papp, Eva's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

38
Telecommunications (1 filing)

Telecommunications

Frequently Asked Questions

How many trademarks does Papp, Eva have?

Papp, Eva has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Papp, Eva file in?

Papp, Eva files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 38 (Telecommunications). Class 35 covers advertising; business management; business administration; office functions.

What are Papp, Eva's most well-known trademarks?

Papp, Eva's registered trademark portfolio includes well-known marks such as DAE NOVA. These are among 1 currently registered trademark in the portfolio.

What is Papp, Eva's trademark registration success rate?

Papp, Eva has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.